CD8A and breast cancer: In support of this notion, a reduction in the number of αSMA-expressing CAFs in murine mammary tumors upon endo180 genetic deletion is reported to inversely correlate with CD8+ T cell infiltration, leading to enhanced immune checkpoint inhibitor efficacy in vivo [245].